Advertisement

Topics

A First for Giant Cell Arteritis

20:00 EDT 3 Jul 2017 | JAMA

A newly approved indication for tocilizumab is the first FDA-approved treatment for giant cell arteritis, a form of vasculitis.

Original Article: A First for Giant Cell Arteritis

NEXT ARTICLE

More From BioPortfolio on "A First for Giant Cell Arteritis"

Advertisement
Quick Search
Advertisement
Advertisement